In a patient on lithium who is increasing fluid intake but still has concentrated urine, what is the cause and how should it be managed?

Lithium-Induced Nephrogenic Diabetes Insipidus

This patient has developed lithium-induced nephrogenic diabetes insipidus (NDI), where the kidney has lost its ability to respond to vasopressin despite increasing endogenous production—drinking more fluids will not concentrate the urine because the collecting ducts cannot respond to the hormone signal.

Understanding the Mechanism

Lithium enters the collecting duct principal cells and disrupts vasopressin-regulated water handling by downregulating aquaporin-2 channels 1, 2. The paradox you're observing—increased fluid intake but persistent concentrated-appearing or dilute urine with ongoing polyuria—occurs because:

• The kidney cannot respond to vasopressin (ADH), even though the body is producing more of it in response to dehydration 3
• Lithium blocks the action of vasopressin at a site before cyclic AMP, preventing water reabsorption 3
• Simply drinking more water does not fix the underlying concentrating defect 1

Immediate Assessment Required

Check these specific parameters now:

• Serum sodium (hypernatremia is common, often 156-159 mmol/L) 4
• Serum lithium level (toxicity occurs near therapeutic levels) 1, 4
• 24-hour urine volume (polyuria defined as >3 L/day, often 6.5-7.5 L/day in NDI) 4, 5
• Urine osmolality (typically <300 mOsm/kg despite elevated serum osmolality) 4
• Serum creatinine to assess for acute kidney injury 1

Management Algorithm

Step 1: Discontinue or Reduce Lithium Dose

Discontinuing lithium is the most effective intervention if psychiatrically feasible 6. This produces:

• Mean decrease of 747 mL in 24-hour urine volume
• Mean increase of 31 mOsm/kg in urine osmolality 6

If discontinuation is not possible, reduce the lithium dose—higher daily doses (≥1400 mg/d) are independently associated with higher vasopressin levels and greater urine output 5.

Step 2: Initiate Thiazide Diuretic + NSAID Combination

Start hydrochlorothiazide 25-50 mg daily plus indomethacin 50 mg twice daily (or another NSAID) 4, 7. This combination:

• Reduces urine output by approximately 40% compared to pretreatment 7
• Works by inducing mild volume depletion, which increases proximal sodium and water reabsorption
• NSAIDs inhibit prostaglandin synthesis, enhancing water reabsorption 7

Critical caveat: Thiazides and NSAIDs can both increase lithium levels by reducing renal clearance 2. Monitor lithium levels closely and expect to reduce lithium dose by 25-50%.

Step 3: Consider Adding Desmopressin

If thiazide + NSAID combination is insufficient, add desmopressin 10-20 mcg intranasally or 0.1-0.2 mg orally 7. Recent evidence shows:

• Desmopressin can reduce urine output by approximately 70% when combined with thiazides and NSAIDs 7
• This challenges the traditional teaching that desmopressin is ineffective in NDI 7
• Some residual vasopressin responsiveness may persist even in lithium-induced NDI 4, 7

Step 4: Amiloride as Alternative

Amiloride 5-10 mg twice daily can be used instead of thiazides, particularly if the patient has contraindications to thiazides 6, 2. Amiloride blocks the epithelial sodium channel through which lithium enters collecting duct cells, directly preventing lithium's toxic effect 2.

Acute Management if Hypernatremic

If serum sodium is elevated (>150 mmol/L):

• Administer IV 5% dextrose for free-water replacement 4
• Correct sodium slowly (no faster than 10-12 mmol/L per 24 hours) to avoid cerebral edema
• Supplement potassium and bicarbonate as needed for associated electrolyte abnormalities 4
• Do not rely on oral water intake alone—the patient cannot concentrate urine to conserve water 4

Dietary Modification

Reduce daily osmolar intake (restrict salt and protein), as higher osmolar intake is independently associated with higher 24-hour urine output 5. This is often overlooked but can meaningfully reduce polyuria.

Critical Pitfall to Avoid

Do not assume the patient is simply not drinking enough water. The concentrated appearance may be misleading, or you may be observing inappropriately dilute urine for the degree of dehydration. The fundamental problem is vasopressin resistance, not inadequate fluid intake 1, 2. Telling the patient to "just drink more" without addressing the underlying NDI will lead to persistent hypernatremia and potential lithium toxicity from dehydration-induced lithium retention 1.

Long-Term Monitoring

• 24-hour urine volume and early morning urine osmolality every 3-6 months 6
• Serum creatinine and eGFR to detect chronic tubulointerstitial nephropathy 1, 2
• Lithium levels more frequently when adjusting diuretics or NSAIDs 2

The condition is usually reversible when lithium is discontinued 1, but chronic morphologic changes with interstitial fibrosis can occur with prolonged exposure 1, 2.